John A. DeMattei

474 total citations
16 papers, 334 citations indexed

About

John A. DeMattei is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, John A. DeMattei has authored 16 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in John A. DeMattei's work include Asymmetric Synthesis and Catalysis (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Synthesis and Catalytic Reactions (5 papers). John A. DeMattei is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Synthesis and Catalytic Reactions (5 papers). John A. DeMattei collaborates with scholars based in United States. John A. DeMattei's co-authors include Robert W. Armstrong, James J.‐W. Duan, Jiang‐Ping Wu, Yoshito Kishi, Wanjun Zheng, Paul J. Nichols, Lee S. Chong, Anthony K. Ogawa, Anthony D. Piscopio and Tsung‐Hsun Chuang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and The Journal of Organic Chemistry.

In The Last Decade

John A. DeMattei

16 papers receiving 318 citations

Peers

John A. DeMattei
Rebecca A. Urbanek United States
Jiang‐Ping Wu United States
Édouard Untersteller United States
David A. Favor United States
Franz Schwarzenbach Switzerland
Regina Zibuck United States
J. Tiebes United States
Graham L. Simpson United Kingdom
Josep Aiguadé United States
Robert J. Aversa United States
Rebecca A. Urbanek United States
John A. DeMattei
Citations per year, relative to John A. DeMattei John A. DeMattei (= 1×) peers Rebecca A. Urbanek

Countries citing papers authored by John A. DeMattei

Since Specialization
Citations

This map shows the geographic impact of John A. DeMattei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. DeMattei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. DeMattei more than expected).

Fields of papers citing papers by John A. DeMattei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. DeMattei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. DeMattei. The network helps show where John A. DeMattei may publish in the future.

Co-authorship network of co-authors of John A. DeMattei

This figure shows the co-authorship network connecting the top 25 collaborators of John A. DeMattei. A scholar is included among the top collaborators of John A. DeMattei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. DeMattei. John A. DeMattei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Corr, Bradley R., S. Lindsey Davis, Christopher H. Lieu, et al.. (2023). First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers. 16(1). 91–91. 7 indexed citations
2.
Diamond, Jennifer R., Todd M. Pitts, Dana Ungermannova, et al.. (2021). Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Molecular Cancer Therapeutics. 21(3). 397–406. 10 indexed citations
3.
Corr, Bradley R., Jose M. Pacheco, S. Lindsey Davis, et al.. (2021). Phase 1 study of OKI-179, an oral class 1-selective depsipeptide HDAC inhibitor, in patients with advanced solid tumors: Final results.. Journal of Clinical Oncology. 39(15_suppl). 3075–3075. 4 indexed citations
4.
Diamond, John B., Gary Gordon, Bradley R. Corr, et al.. (2020). Initial results from a phase 1 trial of OKI-179, an oral Class 1-selective depsipeptide HDAC inhibitor, in patients with advanced solid tumors. European Journal of Cancer. 138. S12–S12. 1 indexed citations
5.
Diamond, Jennifer R., Xuedong Liu, Gilad S. Gordon, et al.. (2019). Abstract B007: OKI-179 is a novel, oral, class I specific histone deacetylase inhibitor in phase 1 clinical trials. Molecular Cancer Therapeutics. 18(12_Supplement). B007–B007. 2 indexed citations
6.
7.
8.
Barnes, David M., John A. DeMattei, David R. Hill, et al.. (2003). A highly diastereoselective vinylogous Mannich condensation and 1,4-conjugate addition of (Z)-propenyl cuprate in the synthesis of an influenza neuraminidase inhibitor. Tetrahedron Asymmetry. 14(22). 3541–3551. 30 indexed citations
9.
Stoner, Eric J., Matthew J. Peterson, M.S. Allen, et al.. (2003). Allylation of Erythromycin Derivatives:  Introduction of Allyl Substituents into Highly Hindered Alcohols. The Journal of Organic Chemistry. 68(23). 8847–8852. 17 indexed citations
10.
DeMattei, John A., et al.. (2001). An Efficient Synthesis of the Taxane-Derived Anticancer Agent ABT-271. The Journal of Organic Chemistry. 66(10). 3330–3337. 11 indexed citations
11.
Leanna, M. Robert, et al.. (2000). Synthesis of the C-13 Side Chain Precursors of the 9-Dihydrotaxane Analogue ABT-271. Organic Letters. 2(23). 3627–3630. 5 indexed citations
12.
13.
Zheng, Wanjun, et al.. (1996). Complete Relative Stereochemistry of Maitotoxin. Journal of the American Chemical Society. 118(34). 7946–7968. 120 indexed citations
14.
DeMattei, John A., et al.. (1996). Asymmetric Synthesis of Calyculin C. 1. Synthesis of the C1−C25 Fragment. The Journal of Organic Chemistry. 61(18). 6139–6152. 31 indexed citations
15.
Ogawa, Anthony K., et al.. (1996). Asymmetric Synthesis of Calyculin C. 2. Synthesis of the C26−C37 Fragment and Model Wittig Couplings. The Journal of Organic Chemistry. 61(18). 6153–6161. 20 indexed citations
16.
Armstrong, Robert W. & John A. DeMattei. (1991). Stereoselective methylations of bicyclic lactams derived from pyroglutamic acid. Tetrahedron Letters. 32(41). 5749–5752. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca A. Urbanek Breakdown of academic impact, for papers by Jiang‐Ping Wu Breakdown of academic impact, for papers by Édouard Untersteller Breakdown of academic impact, for papers by David A. Favor Breakdown of academic impact, for papers by Franz Schwarzenbach Breakdown of academic impact, for papers by Regina Zibuck Breakdown of academic impact, for papers by J. Tiebes Breakdown of academic impact, for papers by Graham L. Simpson Breakdown of academic impact, for papers by Josep Aiguadé Breakdown of academic impact, for papers by Robert J. Aversa
Rankless by CCL
2026